Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.07 | N/A |
| PEG Ratio (TTM) | 1.64 | N/A |
| P/S Ratio (TTM) | 3.12 | N/A |
| P/B Ratio (TTM) | 1.51 | N/A |
| P/FCF Ratio (TTM) | 14.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.23 | N/A |
| Price to 5YR AVG FCF Ratio | 15.12 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.98% | N/A |
| ROE (TTM) | 9.24% | N/A |
| Net Profit Margin (TTM) | 18.45% | N/A |
| ROIC 5YR AVG | 14.05% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.73% | 14.31% | 3.39% |
| Revenue | 5.93% | 3.77% | 2.95% |
| Net Income | 12.00% | 14.05% | 3.69% |
| Cash Flow | 2.05% | 2.45% | 1.90% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 8.59 | N/A |
| Quick Ratio (TTM) | 8.59 | N/A |
| D/E Ratio (TTM) | 0.30 | N/A |
| Interest Coverage (TTM) | 0.05 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.48 | N/A |
| LTL to 5YR AVG FCF | 1.66 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.56% | N/A |